Item Type | Name |
Concept
|
Alanine Transaminase
|
Concept
|
Activities of Daily Living
|
Concept
|
Fabry Disease
|
Concept
|
Aged, 80 and over
|
Concept
|
Aldosterone
|
Concept
|
Australia
|
Concept
|
Acute-Phase Proteins
|
Concept
|
Aged
|
Concept
|
Amino Acids
|
Concept
|
Biphenyl Compounds
|
Concept
|
African Americans
|
Concept
|
Blood Flow Velocity
|
Concept
|
Amino Acid Sequence
|
Concept
|
Administration, Oral
|
Concept
|
Alcohol Drinking
|
Concept
|
Aldehyde Oxidoreductases
|
Concept
|
Calcium Phosphates
|
Concept
|
Intracranial Aneurysm
|
Concept
|
Analgesics
|
Concept
|
Aorta
|
Concept
|
Amino Acids, Branched-Chain
|
Concept
|
Chromosomes, Human, Pair 11
|
Concept
|
Chromosomes, Human, Pair 2
|
Concept
|
Antihypertensive Agents
|
Concept
|
Analysis of Variance
|
Concept
|
Anthropometry
|
Concept
|
Benzazepines
|
Concept
|
Benzimidazoles
|
Concept
|
Atenolol
|
Concept
|
Bayes Theorem
|
Concept
|
Benzoates
|
Concept
|
Attitude
|
Concept
|
Body Height
|
Concept
|
Bone Diseases
|
Concept
|
Calcium, Dietary
|
Concept
|
Attitude to Health
|
Concept
|
Biological Transport
|
Concept
|
Bilirubin
|
Concept
|
Bicarbonates
|
Concept
|
Body Weight
|
Concept
|
Calmodulin-Binding Proteins
|
Concept
|
Career Mobility
|
Concept
|
Cerebral Angiography
|
Concept
|
Chlorthalidone
|
Concept
|
Chromosomes, Human, Pair 12
|
Concept
|
Combined Modality Therapy
|
Concept
|
Blood Pressure Determination
|
Concept
|
Caffeine
|
Concept
|
Creatinine
|
Concept
|
Cooperative Behavior
|
Concept
|
Cholesterol
|
Concept
|
Circadian Rhythm
|
Concept
|
Coronary Artery Disease
|
Concept
|
Diabetes Mellitus, Type 2
|
Concept
|
Cysts
|
Concept
|
Dehydration
|
Concept
|
Cytochrome P-450 Enzyme System
|
Concept
|
Echocardiography
|
Concept
|
Chromatography, Liquid
|
Concept
|
Chromosomes, Human, Pair 17
|
Concept
|
Clinical Protocols
|
Concept
|
Finland
|
Concept
|
Cross-Sectional Studies
|
Concept
|
Indoles
|
Concept
|
Georgia
|
Concept
|
Family Relations
|
Concept
|
Fasting
|
Concept
|
Dialysis
|
Concept
|
Obesity
|
Concept
|
Hydrochlorothiazide
|
Concept
|
Image Interpretation, Computer-Assisted
|
Concept
|
Mosaicism
|
Concept
|
Pharmacogenetics
|
Concept
|
Metoprolol
|
Concept
|
Mice, Transgenic
|
Concept
|
Organ Size
|
Concept
|
Puerto Rico
|
Concept
|
Middle Aged
|
Concept
|
Iothalamic Acid
|
Concept
|
Cholesterol, HDL
|
Concept
|
Nephritis, Hereditary
|
Concept
|
Genetic Markers
|
Concept
|
Renal Circulation
|
Concept
|
Cohort Studies
|
Concept
|
Renal Artery
|
Concept
|
Polycystic Kidney Diseases
|
Concept
|
Kininogens
|
Concept
|
Mass Spectrometry
|
Concept
|
Stress, Psychological
|
Concept
|
Histones
|
Concept
|
Humans
|
Concept
|
Body Mass Index
|
Concept
|
Tetrazoles
|
Concept
|
United States
|
Concept
|
Sequence Homology, Amino Acid
|
Concept
|
Uric Acid
|
Concept
|
Biomarkers
|
Concept
|
Sodium Channels
|
Concept
|
Lipase
|
Concept
|
Blood Pressure Monitoring, Ambulatory
|
Concept
|
Cytochrome P-450 CYP11B2
|
Concept
|
Up-Regulation
|
Concept
|
Observer Variation
|
Concept
|
Antigens, CD
|
Concept
|
Rats, Sprague-Dawley
|
Concept
|
N-Acetylgalactosaminyltransferases
|
Concept
|
Case-Control Studies
|
Concept
|
Methylation
|
Concept
|
Natriuresis
|
Concept
|
North America
|
Concept
|
Angiopoietin-2
|
Concept
|
Hypertrophy, Left Ventricular
|
Concept
|
Polycystic Kidney, Autosomal Recessive
|
Concept
|
Bisoprolol
|
Concept
|
Mice, Knockout
|
Concept
|
Receptors, Adrenergic, beta-2
|
Concept
|
Glucose Transporter Type 2
|
Concept
|
Databases as Topic
|
Concept
|
Cytochrome P-450 CYP2D6
|
Concept
|
Protein Transport
|
Concept
|
Amino Acids, Aromatic
|
Concept
|
Cross-Over Studies
|
Concept
|
Lipopolysaccharide Receptors
|
Concept
|
Cardiac-Gated Imaging Techniques
|
Concept
|
Ethnopharmacology
|
Concept
|
Atherosclerosis
|
Concept
|
Proteomics
|
Concept
|
Receptor, Angiotensin, Type 1
|
Concept
|
Hypoxia-Inducible Factor 1, alpha Subunit
|
Concept
|
Angiotensin II Type 1 Receptor Blockers
|
Concept
|
Chloride Channels
|
Concept
|
Parents
|
Concept
|
Internet
|
Concept
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors
|
Concept
|
Heterotrimeric GTP-Binding Proteins
|
Concept
|
Interleukin-18
|
Concept
|
Retinal Dehydrogenase
|
Concept
|
Organic Cation Transport Proteins
|
Concept
|
Mice
|
Concept
|
Biomedical Research
|
Concept
|
Rats
|
Concept
|
Obesity, Abdominal
|
Concept
|
CCAAT-Enhancer-Binding Protein-delta
|
Concept
|
Sorting Nexins
|
Concept
|
Immunoprecipitation
|
Concept
|
Epithelial Sodium Channels
|
Concept
|
Multivariate Analysis
|
Concept
|
Adrenergic beta-1 Receptor Antagonists
|
Concept
|
Tuberous Sclerosis
|
Concept
|
Receptors, Adrenergic, beta-1
|
Concept
|
Urinalysis
|
Concept
|
Polycystic Kidney, Autosomal Dominant
|
Concept
|
Chemokine CCL2
|
Concept
|
Chemical and Drug Induced Liver Injury
|
Concept
|
Gadolinium DTPA
|
Concept
|
ADP-ribosyl Cyclase
|
Concept
|
Organic Anion Transporters
|
Concept
|
Transcriptome
|
Concept
|
Receptors, Interleukin-18
|
Concept
|
Lipocalins
|
Concept
|
Metabolomics
|
Concept
|
Angiotensin Receptor Antagonists
|
Concept
|
RNA, Small Interfering
|
Concept
|
Protein Kinase C-alpha
|
Concept
|
Plasma Membrane Calcium-Transporting ATPases
|
Concept
|
Automation, Laboratory
|
Concept
|
Calcium Channel Blockers
|
Concept
|
Chromosomes, Human, Pair 16
|
Concept
|
Curriculum
|
Concept
|
Florida
|
Concept
|
Follow-Up Studies
|
Concept
|
Kidney Calculi
|
Concept
|
Longitudinal Studies
|
Concept
|
Lysine
|
Concept
|
Prospective Studies
|
Concept
|
Rats, Mutant Strains
|
Concept
|
Receptors, Adrenergic, beta
|
Concept
|
Renal Artery Obstruction
|
Concept
|
Retrospective Studies
|
Concept
|
Signal Transduction
|
Concept
|
Databases, Factual
|
Concept
|
Focus Groups
|
Concept
|
Cost of Illness
|
Concept
|
Age of Onset
|
Concept
|
Electrophoresis, Capillary
|
Concept
|
Losartan
|
Concept
|
Genomics
|
Concept
|
MicroRNAs
|
Concept
|
Estrogen Receptor alpha
|
Concept
|
Overweight
|
Concept
|
TRPP Cation Channels
|
Concept
|
Glucose Transporter Type 5
|
Concept
|
Young Adult
|
Concept
|
Patient Safety
|
Academic Article
|
Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study.
|
Academic Article
|
Cystic and inherited kidney diseases.
|
Academic Article
|
Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP).
|
Academic Article
|
Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.
|
Academic Article
|
Plasma renin activity predicts blood pressure responses to beta-blocker and thiazide diuretic as monotherapy and add-on therapy for hypertension.
|
Academic Article
|
Blood pressure in early autosomal dominant polycystic kidney disease.
|
Academic Article
|
Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.
|
Academic Article
|
Hypertension in autosomal dominant polycystic kidney disease.
|
Academic Article
|
Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease.
|
Academic Article
|
Is diabetes mellitus-linked amino acid signature associated with ß-blocker-induced impaired fasting glucose?
|
Academic Article
|
Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.
|
Academic Article
|
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
|
Academic Article
|
Renal relevant radiology: radiologic imaging in autosomal dominant polycystic kidney disease.
|
Academic Article
|
Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic.
|
Academic Article
|
Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience.
|
Academic Article
|
Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio.
|
Academic Article
|
Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide.
|
Academic Article
|
Baseline predictors of central aortic blood pressure: a PEAR substudy.
|
Academic Article
|
Reproducibility of blood pressure response to hydrochlorothiazide.
|
Academic Article
|
Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome.
|
Academic Article
|
Demographic, environmental, and genetic predictors of metabolic side effects of hydrochlorothiazide treatment in hypertensive subjects.
|
Academic Article
|
PTPRD gene associated with blood pressure response to atenolol and resistant hypertension.
|
Academic Article
|
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
|
Academic Article
|
Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease.
|
Academic Article
|
A multilocus approach to the antihypertensive pharmacogenetics of hydrochlorothiazide.
|
Academic Article
|
WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic.
|
Academic Article
|
Effects of endothelial nitric oxide synthase, alpha-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide.
|
Academic Article
|
Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis.
|
Academic Article
|
Comparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: the consortium of radiologic imaging studies of polycystic kidney disease cohort.
|
Academic Article
|
Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
|
Academic Article
|
MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement.
|
Academic Article
|
Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study.
|
Academic Article
|
Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease.
|
Academic Article
|
Evaluation of urine biomarkers of kidney injury in polycystic kidney disease.
|
Academic Article
|
Predictors for glucose change in hypertensive participants following short-term treatment with atenolol or hydrochlorothiazide.
|
Academic Article
|
A Physiologic Approach to the Pharmacogenomics of Hypertension.
|
Academic Article
|
Genomic association analysis of common variants influencing antihypertensive response to hydrochlorothiazide.
|
Academic Article
|
Large-scale gene-centric analysis identifies polymorphisms for resistant hypertension.
|
Academic Article
|
PROX1 gene variant is associated with fasting glucose change after antihypertensive treatment.
|
Academic Article
|
TET2 and CSMD1 genes affect SBP response to hydrochlorothiazide in never-treated essential hypertensives.
|
Academic Article
|
Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study.
|
Academic Article
|
Predictors of blood pressure response to the angiotensin receptor blocker candesartan in essential hypertension.
|
Academic Article
|
Volume progression in polycystic kidney disease.
|
Academic Article
|
Kininogen gene (KNG) variation has a consistent effect on aldosterone response to antihypertensive drug therapy: the GERA study.
|
Academic Article
|
Association of branched and aromatic amino acids levels with metabolic syndrome and impaired fasting glucose in hypertensive patients.
|
Academic Article
|
Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.
|
Academic Article
|
Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response.
|
Academic Article
|
Effects of genetic variation in H3K79 methylation regulatory genes on clinical blood pressure and blood pressure response to hydrochlorothiazide.
|
Academic Article
|
Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension.
|
Academic Article
|
Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide.
|
Academic Article
|
Angiotensin blockade in late autosomal dominant polycystic kidney disease.
|
Academic Article
|
A novel simple method for determining CYP2D6 gene copy number and identifying allele(s) with duplication/multiplication.
|
Academic Article
|
Genomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker.
|
Academic Article
|
Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.
|
Academic Article
|
Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.
|
Academic Article
|
Comparison of office, ambulatory, and home blood pressure antihypertensive response to atenolol and hydrochlorthiazide.
|
Academic Article
|
Liver involvement in early autosomal-dominant polycystic kidney disease.
|
Academic Article
|
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.
|
Academic Article
|
Mutations in GANAB, Encoding the Glucosidase IIa Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease.
|
Academic Article
|
Renal volume in children with ADPKD: size matters.
|
Academic Article
|
Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies.
|
Academic Article
|
A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.
|
Academic Article
|
The role of parental hypertension in the frequency and age of diagnosis of hypertension in offspring with autosomal-dominant polycystic kidney disease.
|
Academic Article
|
Comparison of Blood Pressure Control Rates Among Recommended Drug Selection Strategies for Initial Therapy of Hypertension.
|
Academic Article
|
Reproducibility of Genotypes as Measured by the Affymetrix GeneChip® 100K Human Mapping Array Set.
|
Academic Article
|
Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial.
|
Academic Article
|
Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.
|
Academic Article
|
Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes.
|
Academic Article
|
Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease.
|
Academic Article
|
Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data.
|
Academic Article
|
Treatment of autosomal dominant polycystic kidney disease (ADPKD): the new horizon for children with ADPKD.
|
Academic Article
|
Automated Segmentation of Kidneys from MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease.
|
Academic Article
|
Automated segmentation of liver and liver cysts from bounded abdominal MR images in patients with autosomal dominant polycystic kidney disease.
|
Academic Article
|
Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.
|
Academic Article
|
Autosomal dominant polycystic kidney disease: time for a change?
|
Academic Article
|
Mechanisms and management of hypertension in autosomal dominant polycystic kidney disease.
|
Academic Article
|
Polycystic kidney disease: The cadence of kidney growth in ADPKD.
|
Academic Article
|
The HALT polycystic kidney disease trials: design and implementation.
|
Academic Article
|
Gastrointestinal Manifestations of Autosomal-Dominant Polycystic Kidney Disease.
|
Academic Article
|
Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial.
|
Academic Article
|
Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial.
|
Academic Article
|
Genome-Wide Prioritization and Transcriptomics Reveal Novel Signatures Associated With Thiazide Diuretics Blood Pressure Response.
|
Academic Article
|
Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenolol.
|
Academic Article
|
Novel plasma biomarker of atenolol-induced hyperglycemia identified through a metabolomics-genomics integrative approach.
|
Academic Article
|
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
|
Academic Article
|
Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
|
Academic Article
|
Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
|
Academic Article
|
New treatment paradigms for ADPKD: moving towards precision medicine.
|
Academic Article
|
A Patient with a Novel Gene Mutation Leading to Autosomal Dominant Polycystic Kidney Disease.
|
Academic Article
|
Hypoxia-Inducible Factor 1a (HIF-1a), Angiopoietin-2 (ANG-2) and Endocan: Novel Biomarkers of Disease Progression Involving Polycystic Kidney Disease.
|
Academic Article
|
Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics.
|
Academic Article
|
Nurturing passion in a time of academic climate change: the modern-day challenge of junior faculty development.
|
Academic Article
|
Whole Transcriptome Sequencing Analyses Reveal Molecular Markers of Blood Pressure Response to Thiazide Diuretics.
|
Academic Article
|
Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease.
|
Academic Article
|
Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials.
|
Academic Article
|
Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses).
|
Academic Article
|
Tolerability of Aquaretic-Related Symptoms Following Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results From TEMPO 3:4.
|
Academic Article
|
Blood pressure response to metoprolol and chlorthalidone in European and African Americans with hypertension.
|
Academic Article
|
Blood pressure signature genes and blood pressure response to thiazide diuretics: results from the PEAR and PEAR-2 studies.
|
Academic Article
|
Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/ß-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials.
|
Academic Article
|
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
|
Academic Article
|
Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial.
|
Academic Article
|
Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?
|
Academic Article
|
A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan.
|
Academic Article
|
Autosomal dominant polycystic kidney disease.
|
Academic Article
|
Targeted sequencing identifies a missense variant in the BEST3 gene associated with antihypertensive response to hydrochlorothiazide.
|
Academic Article
|
Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapy.
|
Academic Article
|
Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort.
|
Academic Article
|
Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study.
|
Academic Article
|
Plasma Renin Activity Is a Predictive Biomarker of Blood Pressure Response in European but not in African Americans With Uncomplicated Hypertension.
|
Academic Article
|
Effect of plasma MicroRNA on antihypertensive response to beta blockers in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) studies.
|
Academic Article
|
The future of pharmacogenetics in the treatment of hypertension.
|
Academic Article
|
Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease.
|
Academic Article
|
Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.
|
Academic Article
|
Genomic Association Analysis Reveals Variants Associated With Blood Pressure Response to Beta-Blockers in European Americans.
|
Academic Article
|
Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease.
|
Academic Article
|
ß2 -Adrenergic Receptor Gene Affects the Heart Rate Response of ß-Blockers: Evidence From 3 Clinical Studies.
|
Academic Article
|
Genome-Wide Meta-Analysis of Blood Pressure Response to ß1-Blockers: Results From ICAPS (International Consortium of Antihypertensive Pharmacogenomics Studies).
|
Academic Article
|
Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers.
|
Academic Article
|
Genome Wide Analysis Approach Suggests Chromosome 2 Locus to be Associated with Thiazide and Thiazide Like-Diuretics Blood Pressure Response.
|
Academic Article
|
Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients.
|
Academic Article
|
A Practical Approach to Polycystic Liver Disease.
|
Academic Article
|
Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney Disease.
|
Academic Article
|
The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD.
|
Academic Article
|
Advancing Nephrology: Division Leaders Advise ASN.
|
Academic Article
|
'A sword of Damocles': patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study.
|
Academic Article
|
Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity Scores.
|
Academic Article
|
Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
|
Academic Article
|
Race-Specific Comparisons of Antihypertensive and Metabolic Effects of Hydrochlorothiazide and Chlorthalidone.
|
Academic Article
|
Sex Differences of Kidney Stone Urine Risk Factors after Roux-en-Y Gastric Bypass.
|
Academic Article
|
The Effect of Tolvaptan on BP in Polycystic Kidney Disease: A Post Hoc Analysis of the TEMPO 3:4 Trial.
|
Academic Article
|
Patient-reported outcome measures for pain in autosomal dominant polycystic kidney disease: A systematic review.
|
Academic Article
|
Metabolomics Signature of Plasma Renin Activity and Linkage with Blood Pressure Response to Beta Blockers and Thiazide Diuretics in Hypertensive European American Patients.
|
Academic Article
|
PKD1 Compared With PKD2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies.
|
Academic Article
|
Establishing a core outcome measure for pain in patients with autosomal dominant polycystic kidney disease: a consensus workshop report.
|
Academic Article
|
Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease.
|
Academic Article
|
Emerging Role of Clinical Genetics in CKD.
|
Academic Article
|
Polycystic Kidney Disease in the Real World.
|
Academic Article
|
Controversies in renal artery stenosis: a review by the American Society of Nephrology Advisory Group on Hypertension.
|
Academic Article
|
Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration Definitions.
|
Academic Article
|
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome.
|
Academic Article
|
Health Disparities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) in the United States.
|
Academic Article
|
Influence of Genetic West African Ancestry on Metabolomics among Hypertensive Patients.
|
Academic Article
|
Effects of Bardoxolone Methyl in Alport Syndrome.
|
Academic Article
|
The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKD.
|
Academic Article
|
Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation.
|
Concept
|
Lipocalin-2
|
Concept
|
Alpha-Ketoglutarate-Dependent Dioxygenase FTO
|
Concept
|
Circulating MicroRNA
|
Concept
|
Essential Hypertension
|
Concept
|
Nedd4 Ubiquitin Protein Ligases
|
Concept
|
Bestrophins
|
Concept
|
Apolipoprotein L1
|
Concept
|
Antidiuretic Hormone Receptor Antagonists
|
Grant
|
Symposium for Molecular and Therapeutic Insights in PKD
|
Grant
|
Limited Competition: Clinical Centers for the HALT-Polycystic Kidney Disease Tria
|
Academic Article
|
Intracranial Aneurysms in ADPKD: How Far Have We Come?
|
Academic Article
|
OVERTURE: A Worldwide, Prospective, Observational Study of Disease Characteristics in Patients With ADPKD.
|
Academic Article
|
Magnetic resonance imaging preprocessing and radiomic features for classification of autosomal dominant polycystic kidney disease genotype.
|
Academic Article
|
Circulating microRNA Biomarkers of Thiazide Response in Hypertension.
|